Search results
Results from the WOW.Com Content Network
President Benigno Aquino III at the launching of the dengue vaccine school-based immunization program. In April 2016, the DOH launched the dengue vaccination campaign in Central Luzon, Calabarzon and Metro Manila, where about 700,000 individuals received at least one dose of the vaccine. [11] The government paid P3.5-billion for the vaccine. [10]
In the said article, it was stating that in an Idiopathic Thrombocytopenic purpura or ITP case a patient remains normal even with 10K platelet count, if the patient is always hydrated. [6] Platelet transfusion may present a wrong picture of the water/fluid leak of the Dengue infected patient, hence it should be avoided and proper hydration ...
The 2019–2020 dengue fever epidemic was an epidemic of the infectious disease dengue fever in several countries of Southeast Asia, including the Philippines, Malaysia, Vietnam, and Bangladesh, [1] Pakistan, [2] India, Thailand, Singapore, and Laos. [3]
Mild cases of dengue fever can easily be confused with several common diseases including Influenza, measles, chikungunya, and zika. [61] [62] Dengue, chikungunya and zika share the same mode of transmission (Aedes mosquitoes) and are often endemic in the same regions, so that it is possible to be infected simultaneously by more than one disease ...
Epidemic dengue has become more common since the 1980s. By the late 1990s, dengue was the most important mosquito-borne disease affecting humans after malaria, with around 40 million cases of dengue fever and several hundred thousand cases of dengue hemorrhagic fever each year. Significant outbreaks of dengue fever tend to occur every five or ...
At EW 19 in Late May, Brazil made up the vast majority of cases of dengue fever reported in Latin America and the Caribbean in 2024, with 83% of suspected cases arising from Brazil, along with 79.4% of deaths. 6,803,727 cases were reported, and 2,897 deaths have been reported.
Dengue virus (DENV) is the cause of dengue fever.It is a mosquito-borne, single positive-stranded RNA virus of the family Flaviviridae; genus Flavivirus. [1] [2] Four serotypes of the virus have been found, and a reported fifth has yet to be confirmed, [3] [4] [5] all of which can cause the full spectrum of disease. [1]
Dengue vaccine is a vaccine used to prevent dengue fever in humans. [9] Development of dengue vaccines began in the 1920s but was hindered by the need to create immunity against all four dengue serotypes. [10] As of 2023, there are two commercially available vaccines, sold under the brand names Dengvaxia and Qdenga. [11] [12]